We also accept CareCredit and offer financing options to make treatment more manageable
That number has been rising for decades, and research makes clear that it rarely resolves on its own without support
Boost before you go
Upper respiratory tract infections were reported in 14.2% of patients receiving 4mg of retatrutide, 12.2% on 9mg, and 13.1% on 12mg, compared with 11.6% in the placebo group
Burak Altintas, MD, an orthopedist with UTMB, who was not involved in this study, further highlighted the following limitations of the research: The limitations include retrospective design and likely residual confounding despite matching as fracture risk is influenced by many variables that are not reported [] Further, the comparison group is heterogeneous, combining another GLP-1 receptor agonist (dulaglutide) with two mechanistically different weight-loss medications
In a study involving 24 patients with inadequately controlled type 2 diabetes using metformin at baseline (mean HbA1c, 7.8%), sitagliptin or placebo was given on top of metformin for 12 weeks [37]